Athersys (NASDAQ:ATHX) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

Athersys Stock Performance

Shares of ATHX stock opened at $0.01 on Friday. Athersys has a 12 month low of $0.01 and a 12 month high of $1.99. The stock has a market cap of $339,454.50, a P/E ratio of 0.00 and a beta of -0.90. The company has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.